List of Excipients in API budesonide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing budesonide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | PULMICORT | budesonide | 0186-0916 | LACTOSE | |
| AstraZeneca Pharmaceuticals LP | PULMICORT RESPULES | budesonide | 0186-1988 | ANHYDROUS CITRIC ACID | |
| AstraZeneca Pharmaceuticals LP | PULMICORT RESPULES | budesonide | 0186-1988 | EDETATE DISODIUM | |
| AstraZeneca Pharmaceuticals LP | PULMICORT RESPULES | budesonide | 0186-1988 | POLYSORBATE 80 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing budesonide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 | CITRIC ACID MONOHYDRATE |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 | EDETATE DISODIUM |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 | POLYSORBATE 80 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 | SODIUM CHLORIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for budesonide
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
budesonide drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide, glycopyrrolate, and formoterol fumarate | 0310-4616 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACESULFAME POTASSIUM
budesonide drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ACETYLTRIBUTYL CITRATE
budesonide drug variants containing ACETYLTRIBUTYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| Sandoz Inc | budesonide | 0781-2072 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ACETYLTRIBUTYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
budesonide drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| Bryant Ranch Prepack | budesonide | 63629-8294 |
| Amneal Pharmaceuticals LLC | budesonide | 65162-778 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
budesonide drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Zydus Lifesciences Limited | budesonide | 70771-1075 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIUM GLYCYRRHIZATE
budesonide drug variants containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
budesonide drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| Physicians Total Care Inc | budesonide | 54868-5774 |
| Aurobindo Pharma Limited | budesonide | 59651-585 |
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DEXTROSE
budesonide drug variants containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Johnson & Johnson Consumer Inc McNeil Consumer Healthcare Division | budesonide | 50580-646 |
| Physicians Total Care Inc | budesonide | 54868-4411 |
| Apotex Corp | budesonide | 60505-0839 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: APAFLURANE
budesonide drug variants containing APAFLURANE
budesonide drug variants not containing APAFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: AQUA
budesonide drug variants containing AQUA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | budesonide | 50090-6590 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing AQUA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
budesonide drug variants containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ASCORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTANE
budesonide drug variants containing BUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | budesonide | 65649-651 |
| Oceanside Pharmaceuticals | budesonide | 68682-658 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing BUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
budesonide drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| Bryant Ranch Prepack | budesonide | 63629-8294 |
| Amneal Pharmaceuticals LLC | budesonide | 65162-778 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE
budesonide drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide, glycopyrrolate, and formoterol fumarate | 0310-4616 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
budesonide drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Walgreens | budesonide | 0363-0048 |
| Rugby Laboratories | budesonide | 0536-1112 |
| Rite Aid | budesonide | 11822-1700 |
| Rite Aid | budesonide | 11822-6000 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
budesonide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Walgreens | budesonide | 0363-0048 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Rite Aid | budesonide | 11822-1700 |
| Rite Aid | budesonide | 11822-6000 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
budesonide drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | budesonide | 65649-651 |
| Oceanside Pharmaceuticals | budesonide | 68682-658 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
budesonide drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Padagis Israel Pharmaceuticals Ltd | budesonide | 45802-627 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CHERRY
budesonide drug variants containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CHERRY
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID
budesonide drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | budesonide | 50090-6590 |
| Rising Pharma Holdings Inc | budesonide | 64980-638 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
budesonide drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| Nephron Pharmaceuticals Corporation | budesonide | 0487-9601 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| Walgreens | budesonide | 0363-0048 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
budesonide drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | budesonide | 54868-4910 |
| Prometheus Laboratories Inc | budesonide | 65483-702 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
budesonide drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| Golden State Medical Supply Inc | budesonide | 60429-264 |
| Carilion Materials Management | budesonide | 68151-4374 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 28
budesonide drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| Mayne Pharma Inc | budesonide | 51862-580 |
| Mayne Pharma Inc | budesonide | 51862-582 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 33
budesonide drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| Mayne Pharma Inc | budesonide | 51862-580 |
| Mayne Pharma Inc | budesonide | 51862-582 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
budesonide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE
budesonide drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Walgreens | budesonide | 0363-0048 |
| Rugby Laboratories | budesonide | 0536-1112 |
| Rite Aid | budesonide | 11822-1700 |
| Rite Aid | budesonide | 11822-6000 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: DEXTROSE MONOHYDRATE
budesonide drug variants containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing DEXTROSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIBUTYL SEBACATE
budesonide drug variants containing DIBUTYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Calliditas Therapeutics AB | budesonide | 81749-004 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing DIBUTYL SEBACATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
budesonide drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| Northstar Rx LLC | budesonide | 16714-829 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
budesonide drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
budesonide drug variants containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
budesonide drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Northstar Rx LLC | budesonide | 16714-829 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| Rising Pharmaceuticals Inc | budesonide | 64980-255 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
budesonide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
budesonide drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
budesonide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
budesonide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| Bryant Ranch Prepack | budesonide | 63629-8294 |
| Amneal Pharmaceuticals LLC | budesonide | 65162-778 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
budesonide drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| Northstar Rx LLC | budesonide | 16714-829 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
budesonide drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7313 |
| Northstar Rx LLC | budesonide | 16714-829 |
| Physicians Total Care Inc | budesonide | 54868-4910 |
| Ferring Pharmaceuticals Inc | budesonide | 55566-1002 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
budesonide drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Sandoz Inc | budesonide | 0781-2072 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
budesonide drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| Sandoz Inc | budesonide | 0781-2072 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
budesonide drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
budesonide drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Walgreens | budesonide | 0363-0048 |
| Rugby Laboratories | budesonide | 0536-1112 |
| Rite Aid | budesonide | 11822-1700 |
| Rite Aid | budesonide | 11822-6000 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROFLUOROCARBON 227EA
budesonide drug variants containing HYDROFLUOROCARBON 227EA
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | budesonide and formoterol fumarate dihydrate | 50090-1403 |
| A-S Medication Solutions | budesonide and formoterol fumarate dihydrate | 50090-6382 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing HYDROFLUOROCARBON 227EA
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
budesonide drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Golden State Medical Supply | budesonide | 51407-224 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
budesonide drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| Mayne Pharma Inc | budesonide | 51862-580 |
| Mayne Pharma Inc | budesonide | 51862-582 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
budesonide drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Golden State Medical Supply | budesonide | 51407-224 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
budesonide drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| Amneal Pharmaceuticals LLC | budesonide | 65162-778 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOBUTANE
budesonide drug variants containing ISOBUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | budesonide | 65649-651 |
| Oceanside Pharmaceuticals | budesonide | 68682-658 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ISOBUTANE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
budesonide drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Lifesciences Limited | budesonide | 70771-1075 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
budesonide drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| Rebel Distributors Corp | budesonide | 21695-291 |
| A-S Medication Solutions | budesonide | 50090-2239 |
| A-S Medication Solutions | budesonide | 50090-6796 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
budesonide drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: LECITHIN, SOYBEAN
budesonide drug variants containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Golden State Medical Supply | budesonide | 51407-224 |
| Golden State Medical Supply Inc | budesonide | 51407-824 |
| Bryant Ranch Prepack | budesonide | 63629-9093 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing LECITHIN, SOYBEAN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
budesonide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
budesonide drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
budesonide drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Calliditas Therapeutics AB | budesonide | 81749-004 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID
budesonide drug variants containing METHACRYLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Physicians Total Care Inc | budesonide | 54868-4910 |
| Rising Pharmaceuticals Inc | budesonide | 64980-255 |
| Prometheus Laboratories Inc | budesonide | 65483-702 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing METHACRYLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
budesonide drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Mayne Pharma Inc | budesonide | 51862-582 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
budesonide drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Golden State Medical Supply | budesonide | 51407-224 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
budesonide drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | budesonide | 0574-9855 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| Northstar Rx LLC | budesonide | 16714-829 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
budesonide drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 53746-778 |
| Bryant Ranch Prepack | budesonide | 63629-8294 |
| Amneal Pharmaceuticals LLC | budesonide | 65162-778 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE
budesonide drug variants containing MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Rugby Laboratories | budesonide | 0536-1112 |
| Amerisource Bergen | budesonide | 46122-389 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing MICROCRYSTALLINE CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
budesonide drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
budesonide drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: NORFLURANE
budesonide drug variants containing NORFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide, glycopyrrolate, and formoterol fumarate | 0310-4616 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing NORFLURANE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: OLEIC ACID
budesonide drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Calliditas Therapeutics AB | budesonide | 81749-004 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: PEG-20 SORBITAN OLEATE
budesonide drug variants containing PEG-20 SORBITAN OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | budesonide | 50090-6590 |
| A-S Medication Solutions | budesonide inhalation | 50090-7126 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing PEG-20 SORBITAN OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
budesonide drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
budesonide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| Mayne Pharma Inc | budesonide | 51862-580 |
| Mayne Pharma Inc | budesonide | 51862-582 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1000
budesonide drug variants containing POLYETHYLENE GLYCOL 1000
budesonide drug variants not containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
budesonide drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Golden State Medical Supply | budesonide | 51407-224 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
budesonide drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 60
budesonide drug variants containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | budesonide | 65649-651 |
| Oceanside Pharmaceuticals | budesonide | 68682-658 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
budesonide drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Rebel Distributors Corp | budesonide | 21695-291 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
budesonide drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| Northstar Rx LLC | budesonide | 16714-829 |
| Ferring Pharmaceuticals Inc | budesonide | 55566-1002 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM SORBATE
budesonide drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Walgreens | budesonide | 0363-0048 |
| Rugby Laboratories | budesonide | 0536-1112 |
| Rite Aid | budesonide | 11822-1700 |
| Rite Aid | budesonide | 11822-6000 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
budesonide drug variants containing POVIDONE K25
budesonide drug variants not containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPANE
budesonide drug variants containing PROPANE
| Company | Ingredient | NDC |
|---|---|---|
| Salix Pharmaceuticals Inc | budesonide | 65649-651 |
| Oceanside Pharmaceuticals | budesonide | 68682-658 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing PROPANE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
budesonide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Sandoz Inc | budesonide | 0781-2072 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
budesonide drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
budesonide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ASCORBATE
budesonide drug variants containing SODIUM ASCORBATE
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM ASCORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
budesonide drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| TAKEDA PHARMACEUTICALS AMERICA INC | budesonide | 64764-105 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
budesonide drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| Walgreens | budesonide | 0363-0048 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
budesonide drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| Nephron Pharmaceuticals Corporation | budesonide | 0487-9601 |
| NorthStar RxLLC | budesonide | 16714-018 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| Walgreens | budesonide | 0363-0048 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
budesonide drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Mylan Institutional Inc | budesonide | 51079-020 |
| Golden State Medical Supply Inc | budesonide | 60429-264 |
| Rising Pharmaceuticals Inc | budesonide | 64980-255 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
budesonide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
budesonide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | budesonide | 0591-2510 |
| Golden State Medical Supply | budesonide | 51407-224 |
| Golden State Medical Supply Inc | budesonide | 51407-824 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SOYBEAN LECITHIN
budesonide drug variants containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Santarus Inc | budesonide | 68012-309 |
| Oceanside Pharmaceuticals | budesonide | 68682-309 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
budesonide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Golden State Medical Supply Inc | budesonide | 51407-128 |
| Mayne Pharma Inc | budesonide | 51862-580 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARETH-10
budesonide drug variants containing STEARETH-10
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | budesonide | 45802-627 |
| Salix Pharmaceuticals Inc | budesonide | 65649-651 |
| Oceanside Pharmaceuticals | budesonide | 68682-658 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing STEARETH-10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
budesonide drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | budesonide | 63629-9093 |
| Santarus Inc | budesonide | 68012-309 |
| Oceanside Pharmaceuticals | budesonide | 68682-309 |
| Bryant Ranch Prepack | budesonide | 72162-1898 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
budesonide drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Sandoz Inc | budesonide | 0781-2072 |
| Major Pharmaceuticals | budesonide | 0904-7166 |
| Major Pharmaceuticals | budesonide | 0904-7313 |
| Northstar Rx LLC | budesonide | 16714-829 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
budesonide drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
budesonide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
budesonide drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Golden State Medical Supply Inc | budesonide | 51407-366 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
budesonide drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| Padagis US LLC | budesonide | 0574-9855 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE
budesonide drug variants containing TRISODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | budesonide | 50090-6590 |
| A-S Medication Solutions | budesonide inhalation | 50090-7126 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing TRISODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
budesonide drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Sandoz Inc | budesonide | 0781-7515 |
| A-S Medication Solutions | budesonide | 50090-1467 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| Walgreens | budesonide | 0363-0048 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
budesonide drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6815 |
| Teva Pharmaceuticals USA Inc | budesonide | 0093-6817 |
| Amneal Pharmaceuticals of New York LLC | budesonide | 0115-1687 |
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-1988 |
| >Company | >Ingredient | >NDC |
budesonide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | budesonide | 0186-0916 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-4500 |
| Mylan Pharmaceuticals Inc | budesonide | 0378-7155 |
| Padagis US LLC | budesonide | 0574-9850 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
